Cytokinetics, Incorporated (CYTK)

Cytokinetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	113.02	65.58	112.67	82.99	36.43
Short-Term Investments	501.8	717	358.97	381.08	188.68
Cash & Cash Equivalents	614.82	782.58	471.64	464.06	225.11
Cash Growth	-21.44%	65.93%	1.63%	106.15%	13.27%
Receivables	1.28	0.15	51.82	4.42	5.16
Other Current Assets	11.94	12.46	12.22	5.74	3.48
Total Current Assets	628.05	795.19	535.67	474.22	233.75
Property, Plant & Equipment	147.74	163.19	146.41	16.27	13.41
Long-Term Investments	40.53	46.71	152.05	36.95	42.65
Other Long-Term Assets	8	9.69	7.19	6.36	0
Total Long-Term Assets	196.27	219.59	305.65	59.58	56.06
Total Assets	824.32	1,015	841.32	533.8	289.81
Accounts Payable	21.51	25.61	21.09	8.05	8.16
Deferred Revenue	0	0	87	87	0
Current Debt	27.97	13.79	14.86	2.79	4.62
Other Current Liabilities	53.2	45.22	-51.09	-66.64	13.25
Total Current Liabilities	102.68	84.62	71.86	31.2	26.02
Long-Term Debt	727.8	736.51	255.07	136.15	131.45
Other Long-Term Liabilities	380.16	301.55	270.53	253.07	143.28
Total Long-Term Liabilities	1,108	1,038	525.6	389.22	274.73
Total Liabilities	1,211	1,123	597.46	420.42	300.75
Total Debt	755.77	750.3	269.93	138.94	136.07
Debt Growth	0.73%	177.96%	94.28%	2.11%	215.09%
Retained Earnings	-2,112.24	-1,585.99	-1,207.62	-992.31	-865.02
Comprehensive Income	-0.01	-3.59	-0.87	0.15	0.68
Shareholders' Equity	-386.32	-107.9	243.86	113.38	-10.94
Net Cash / Debt	-140.95	32.28	201.71	325.12	89.04
Net Cash / Debt Growth	-	-84.00%	-37.96%	265.13%	-42.75%
Net Cash Per Share	-1.46	0.36	2.62	5.04	1.55
Working Capital	525.37	710.57	463.81	443.02	207.73
Book Value Per Share	-4.00	-1.20	3.17	1.76	-0.19

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).